Overview

Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The retinal vasculature changes dramatically in patients with diabetic retinopathy especially between non-proliferative and proliferative disease. The retinal vasculature can be imaged and quantified using special dyes. This study will test whether the pattern of the retinal vasculature changes in patients with different levels of diabetic retinopathy can be quantified using computerized image analysis. In addition, the study will evaluate whether new drugs to treat diabetic retinopathy will be able to reverse these vascular changes.
Phase:
Early Phase 1
Details
Lead Sponsor:
National Eye Institute (NEI)
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide